Karofylakis, E.; Thomas, K.; Kavatha, D.; Galani, L.; Tsiodras, S.; Giamarellou, H.; Papaevangelou, V.; Antoniadou, A.
Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study. Viruses 2024, 16, 1241.
https://doi.org/10.3390/v16081241
AMA Style
Karofylakis E, Thomas K, Kavatha D, Galani L, Tsiodras S, Giamarellou H, Papaevangelou V, Antoniadou A.
Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study. Viruses. 2024; 16(8):1241.
https://doi.org/10.3390/v16081241
Chicago/Turabian Style
Karofylakis, Emmanouil, Konstantinos Thomas, Dimitra Kavatha, Lamprini Galani, Sotirios Tsiodras, Helen Giamarellou, Vassiliki Papaevangelou, and Anastasia Antoniadou.
2024. "Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study" Viruses 16, no. 8: 1241.
https://doi.org/10.3390/v16081241
APA Style
Karofylakis, E., Thomas, K., Kavatha, D., Galani, L., Tsiodras, S., Giamarellou, H., Papaevangelou, V., & Antoniadou, A.
(2024). Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study. Viruses, 16(8), 1241.
https://doi.org/10.3390/v16081241
